Skip to main content

Table 1 Forward and reverse sequencing primers

From: Development of an in vitro model of acquired resistance to toceranib phosphate (Palladia®) in canine mast cell tumor

Primer

Sequence range (bp)

Start site

5′-Sequence-3′

FOR1

501–1000

448

GACGGACCCAGAAGTGACC

FOR2

1001–1500

948

CCTTGGAAGTAGTAGATAAAGGATTCA

FOR3

1501–2000

1453

AGTGGTTCAGAGTTCCATCG

FOR4

2001–2500

1948

CAAAGTCTTGAGTTACCTCGG

FOR5

2501–3000

2950

TGTGTGAAGCAGGAGGAGTG

REV1

500–1

552

CTGATCGTGATGCCAGCTT

REV2

1000–501

1040

CAATCAGATCCACATTCTGTCC

REV3

1500--1001

1542

GCAGAACTCCTGCCTACATTG

REV4

2000--1501

2040

TATTCTGTAATGACCAAGGTGGG

REV5

2500--2001

2552

TGAAAATGCTCTCAGGGGC